In the BioHarmony Drug Report Database

"Preview" Icon

Rifampin

Rifadin, Rimactane (rifampin) is a small molecule pharmaceutical. Rifampin was first approved as Rifadin on 1982-01-01. It is used to treat aids-related opportunistic infections, bacterial infections, bacterial meningitis, brucellosis, and haemophilus infections amongst others in the USA. It is known to target solute carrier organic anion transporter family member 1A2, solute carrier organic anion transporter family member 1B1, solute carrier organic anion transporter family member 1B3, and nuclear receptor subfamily 1 group I member 2.

 

Trade Name

 

Rifadin, Rimactane
 

Common Name

 

rifampin
 

ChEMBL ID

 

CHEMBL374478
 

Indication

 

aids-related opportunistic infections, bacterial infections, bacterial meningitis, brucellosis, haemophilus infections, legionnaires' disease, leprosy, staphylococcal infections, tuberculosis
 

Drug Class

 

Tricyclic compounds; antibiotics (rifamycin derivatives)

Image (chem structure or protein)

Rifampin structure rendering